nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0406	0.0406	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0397	0.0397	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0372	0.0372	CbGpPWpGaD
Oxprenolol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0297	0.0297	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.029	0.029	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0241	0.0241	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0236	0.0236	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0202	0.0202	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0198	0.0198	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0171	0.0171	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0171	0.0171	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0167	0.0167	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0167	0.0167	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Oxprenolol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0138	0.0138	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.012	0.012	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.0108	0.0108	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00915	0.00915	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00912	0.00912	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00911	0.00911	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00895	0.00895	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00891	0.00891	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00799	0.00799	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00798	0.00798	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00781	0.00781	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00694	0.00694	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00679	0.00679	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00616	0.00616	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00616	0.00616	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00595	0.00595	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00595	0.00595	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.0056	0.0056	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.0056	0.0056	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.00552	0.00552	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.0054	0.0054	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00517	0.00517	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00506	0.00506	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00493	0.00493	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00493	0.00493	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00459	0.00459	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CHKB—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.0041	0.0041	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00392	0.00392	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00389	0.00389	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00356	0.00356	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00348	0.00348	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00336	0.00336	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00305	0.00305	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CPT1B—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CHKB—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000919	0.000919	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000899	0.000899	CbGpPWpGaD
